Stock Price
0.41
Daily Change
-0.02 -3.57%
Monthly
15.71%
Yearly
305.00%
Q1 Forecast
0.37

Starpharma Holdings reported AUD4.01M in Operating Expenses for its fiscal semester ending in June of 2025.





Operating Expenses Change Date
Medical Developments International AUD 10.02M 9.78M Jun/2025
Mesoblast USD 56.15M 32.57M Jun/2025
Neuren Pharmaceuticals AUD 8.69M 8.72M Jun/2025